CARD17 anticorps (Middle Region)

N° du produit ABIN926695

Détail du produit anti-CARD17 anticorps

Antigène: CARD17 (Caspase Recruitment Domain Family, Member 17 (CARD17))

Épitope: Middle Region

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CARD17 est non-conjugé

Application: Western Blotting (WB)

Purification: Purified

Immunogène: CARD17 antibody was raised in rabbit using the middle region of CARD17 as the immunogen

Information d'application

Indications d'application: Optimal conditions should be determined by the investigator.

Commentaires:

CARD17 Blocking Peptide, catalog no. 33R-5841, is also available for use as a blocking control in assays to test for specificity of this CARD17 antibody

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Concentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Détails sur CARD17

Antigène: CARD17 (Caspase Recruitment Domain Family, Member 17 (CARD17))

Autre désignation: CARD17 (CARD17 Produits)

Synonymes: anticorps INCA, anticorps caspase recruitment domain family member 17, anticorps CARD17

Sujet: As a regulator of procaspase-1/CASP1 activation, CARD17 is implicated in the regulation of the proteolytic maturation of pro-IL-1beta/IL1B and its release during inflammation. CARD17 inhibits the release of IL1B in response to LPS in monocytes. However, unlike CASP1, CARD17 do not induce NF-kappa-B activation. Synonyms: Polyclonal CARD17 antibody, Anti-CARD17 antibody, caspase recruitment domain family, member 17 antibody, INCA antibody.